Date filters select awards with transaction activity in the period. Amounts below are lifetime award obligations. IDV values remain separate.
THE PURPOSE OF THIS TASK ORDER IS THE DEVELOPMENT AND DELIVERY OF A QUALITY ASSURANCE/QUALITY CONTROL (QA/QC) PLAN AND PARTICIPATION IN THE TASK ORDER INITIATION MEETING.Department of Health and Human Services$25.2K obligationsEnds Aug 14, 2021
CONTRACT #HHSN272201800001I; SRI INTERNATIONAL; GMP MANUFACTURING OF OXFENDAZOLE CLINICAL TRIAL MATERIAL AND STABILITY STUDY; OA TASK 75N93021F00006; MIS TASK TOIA21C13PIPB-1…Department of Health and Human Services$630.6K obligationsEnds Jun 2, 2025
IGF::OT::IGF TASK ORDER #3, "CONTINUOUS RODENT AND NON-RODENT PHARMACOKINETIC ASSESSMENTS"Department of Health and Human Services$2.9M obligationsEnds May 19, 2022
NON-CLINICAL SERVICES FOR THE DEVELOPMENT OF INTERVENTIONAL AGENTS FOR INFECTIOUS DISEASESDepartment of Health and Human Services$1.7M obligationsEnds Jan 31, 2023
TASK ORDER NO. 75N94020F00001 TITLE: CHEMICAL SCREENING AND OPTIMIZATION FACILITY - "SCALABLE QUANTITIES OF ACTIVE PHARMACEUTICAL INGREDIENTS"Department of Health and Human Services$315.6K obligationsEnds Sep 23, 2022
HHSN275201500002I - BIOLOGICAL TESTING FACILITY TASK ORDER 16: CLINICAL MANUFACTURING, FORMULATION DEVELOPMENT AND STABILITY TESTING - SRI INTERNATIONAL - CAN 8030701Department of Health and Human Services$834.4K obligationsEnds Mar 19, 2025
75N9420D00003 - BIOLOGICAL TESTING FACILITY: TASK ORDER 2: PRECLINICAL - SRI INTERNATIONAL - CAN 8030701Department of Health and Human Services$2.1M obligationsEnds Sep 3, 2022
CONTRACT: HHSN275201800007I - CHEMICAL SCREENING AND OPTIMIZATION FACILITY TASK ORDER: 75N94021F0000 (TASK ORDER 7)- HIGH THROUGHPUT SCREENING POP: 5/28/21 - 9/30/23Department of Health and Human Services$859.2K obligationsEnds Sep 30, 2024
75N9420D00003 - BIOLOGICAL TESTING FACILITY, TASK ORDER 5: WEBSITE - SRI INTERNATIONAL - CAN 8030701Department of Health and Human Services$196.0K obligationsEnds Jan 6, 2023
INTERVENTIONAL AGENTS CHEMISTRY SERVICESDepartment of Health and Human Services$86.9K obligationsEnds Jan 14, 2027
INVESTIGATION AND OPTIMIZATION OF FG-960 PRECLINICAL FORMULATIONSDepartment of Health and Human Services$218.6K obligationsEnds Sep 30, 2021
AN ORAL THERAPY FOR THE PREVENTION AND TREATMENT OF MALARIA. POP: 09/16/2020 TO 03/15/2021.Department of Health and Human Services$432.4K obligationsEnds Jul 23, 2021
ANIMAL MODEL DEVELOPMENT AND EFFICACY TESTINGDepartment of Health and Human Services$11.2M obligationsEnds Sep 29, 2026
75N94020D00003-BIOLOGICAL TESTING FACILITY (BTF): TASK ORDER 20 - "PRECLINICAL DEVELOPMENT OF CONTRACEPTIVE PRODUCTS".Department of Health and Human Services$1.0M obligationsEnds Sep 26, 2027
NICHD: R&D: ANDROGENIC, ANABOLIC, AND PRECLINICAL SAFETY STUDIES: NON-SEVERABLEDepartment of Health and Human Services$323.9K obligationsEnds Jul 31, 2027
NICHD: R&D: BIOLOGICAL TESTING FACILITY - DRUG PRODUCT MANUFACTURE OF ONGOING CLINICAL DEVELOPMENT: NON-SEVERABLEDepartment of Health and Human Services$349.6K obligationsEnds Jul 31, 2028
PHARMACOKINETICS OF LONG-ACTING PREPARATIONS OF ANTITUBERCULAR DRUGS IN RODENTSDepartment of Health and Human Services$830.6K obligationsEnds Jan 31, 2027
AWARD TASK ORDER 2 - SCALABLE QUANTITIESDepartment of Health and Human Services$773.2K obligationsEnds Sep 24, 2028
NICHD:R&D:TO CONDUCT SCREENING EFFORTS (TASK ORDER 5) FOR THE CHEMICAL SCREENING AND OPTIMIZATION FACILITY AND IDENTIFY NEW CHEMICAL MATTER FOR CONTRACEPTION AND REPRODUCTIVE…Department of Health and Human Services$352.4K obligationsEnds Sep 24, 2028
NONCLINICAL SERVICES FOR THE DEVELOPMENT OF INTERVENTIONAL AGENTS FOR INFECTIOUS DISEASESDepartment of Health and Human Services$5.0M obligationsEnds Mar 13, 2028
TO AWARD TASK ORDER C03Department of Health and Human Services$722.0K obligationsEnds Feb 19, 2032
NICHD: R&D: PRECLINICAL, MANUFACTURING, AND STABILITY STUDIES: NON-SEVERABLEDepartment of Health and Human Services$1.5M obligationsEnds May 31, 2028
ANIMAL MODEL DEVELOPMENT AND EFFICACY TESTING OF CANDIDATE MEDICAL COUNTERMEASURES (MCMS)Department of Health and Human Services$16.2M obligationsEnds Sep 29, 2027
NICHD: R&D: SMALL MOLECULE X-RAY CRYSTALLOGRAPHY: NON-SEVERABLEDepartment of Health and Human Services$348.6K obligationsEnds Oct 26, 2028
NON-CLINICAL STUDIES IN SUPPORT OF IND/NDA/BLA SUBMISSIONSDepartment of Health and Human Services$5.1M obligationsEnds Jul 20, 2027